Youssef Bouferraa

7PUBLICATIONS
10CO-AUTHORS
Molecular targetsMedical bacteriologyHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 07, 2025
Adagrasib in the treatment of colorectal cancer.

Sara F Haddad, Youssef Bouferraa, Kanika G Nair

|Jun 10, 2023
Microbial Influences on Immune Checkpoint Inhibitor Response in Melanoma: The Interplay between Skin and Gut Microbiota.

Youssef Bouferraa, Callie Fares, Maroun Bou Zerdan

|Jan 17, 2023
Thrombotic Microangiopathy in the Setting of Colorectal Cancer: A Therapeutic Challenge with a Bad Prognosis.

Youssef Bouferraa, Yolla Haibe, Hanan Hamdan

|Aug 07, 2021
The Role of Gut Microbiota in Overcoming Resistance to Checkpoint Inhibitors in Cancer Patients: Mechanisms and Challenges.

Youssef Bouferraa, Andrea Chedid, Ghid Amhaz

|Apr 05, 2021
Pathophysiology, clinical findings, and management of Fox-Fordyce disease: A systematic review.

Antoine Salloum, Youssef Bouferraa, Nagham Bazzi

Pageof 2